Direct regulation of myelin protein zero expression by the Egr2 transactivator

被引:84
作者
LeBlanc, SE
Jang, SW
Ward, RM
Wrabetz, L
Svaren, J
机构
[1] Univ Wisconsin, Sch Vet Med, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA
[2] Univ Wisconsin, Sch Vet Med, Grad Program Cellular & Mol Biol, Madison, WI 53706 USA
[3] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA
[4] San Raffaele Sci Inst, Dipartimento Ric Biol & Technol, I-20132 Milan, Italy
关键词
D O I
10.1074/jbc.M512159200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During myelination of the peripheral nervous system, the myelin protein zero (Mpz) gene is induced to produce the most abundant protein component (P-0) of mature myelin. Although the basal embryonic expression of Mpz in Schwann cells has been attributed to regulation by Sox10, the molecular mechanism for the profound up-regulation of this gene during myelination has not been established. In this study, we have identified a highly conserved element within the first intron of the Mpz gene, which contains binding sites for the early growth response 2 (Egr2/Krox20) transcription factor, a critical regulator of peripheral nerve myelination. Egr2 can transactivate the intron element, and the induction is blocked by two known repressors of Egr2 activity. Using chromatin immunoprecipitation assays, we find that Egr2 binds in vivo to the intron element, but not to the Mpz promoter. Known inducers of Mpz expression such as forskolin and insulin-like growth factor-1 also activate the element in an Egr2-dependent manner. In addition, we found that Egr2 can act synergistically with Sox10 to activate this intron element, suggesting a model in which cooperative interactions between Egr2 and Sox10 mediate a large increase in Mpz expression to the high levels found in myelinating Schwann cells.
引用
收藏
页码:5453 / 5460
页数:8
相关论文
共 66 条
[1]   PO IS AN EARLY MARKER OF THE SCHWANN-CELL LINEAGE IN CHICKENS [J].
BHATTACHARYYA, A ;
FRANK, E ;
RATNER, N ;
BRACKENBURY, R .
NEURON, 1991, 7 (05) :831-844
[2]  
Blanchard AD, 1996, J NEUROSCI RES, V46, P630, DOI 10.1002/(SICI)1097-4547(19961201)46:5<630::AID-JNR11>3.0.CO
[3]  
2-0
[4]   Interaction among SOX10 PAX3 and MITF, three genes altered in Waardenburg syndrome [J].
Bondurand, N ;
Pingault, V ;
Goerich, DE ;
Lemort, N ;
Sock, E ;
Le Caignec, C ;
Wegner, M ;
Goossens, M .
HUMAN MOLECULAR GENETICS, 2000, 9 (13) :1907-1917
[5]   Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10 [J].
Bondurand, N ;
Girard, M ;
Pingault, V ;
Lemort, N ;
Dubourg, O ;
Goossens, M .
HUMAN MOLECULAR GENETICS, 2001, 10 (24) :2783-2795
[6]   Multiple regulatory elements control transcription of the peripheral myelin protein zero gene [J].
Brown, AM ;
Lemke, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :28939-28947
[7]   Regulation of insulin-like growth factor-binding protein-5 expression during Schwann cell differentiation [J].
Cheng, HL ;
Shy, M ;
Feldman, EL .
ENDOCRINOLOGY, 1999, 140 (10) :4478-4485
[8]   Simple version of "megaprimer" PCR for site-directed mutagenesis [J].
Colosimo, A ;
Xu, Z ;
Novelli, G ;
Dallapiccola, B ;
Gruenert, DC .
BIOTECHNIQUES, 1999, 26 (05) :870-+
[9]   Functional organization of a Schwann cell enhancer [J].
Denarier, E ;
Forghani, R ;
Farhadi, HF ;
Dib, S ;
Dionne, N ;
Friedman, HC ;
Lepage, P ;
Hudson, TJ ;
Drouin, RG ;
Peterson, A .
JOURNAL OF NEUROSCIENCE, 2005, 25 (48) :11210-11217
[10]  
Désarnaud F, 1998, J NEUROCHEM, V71, P1765